8TG8Z43Y4X | 2727170-18-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶嗪类
• 英文名称: 8TG8Z43Y4X
• 英文别名: 6,10-dihydroxy-8-[1-(4-methoxyphenyl)-2-methylpropan-2-yl]-4,7,9,10-tetrahydropyrido[3,4-h][1,4]benzoxazin-3-one
• CAS: 2727170-18-3
• 化学式: C₂₂H₂₆N₂O₅
• 分子量: 398.5
• InChiKey: FTPSUPSLSTXASK-UHFFFAOYSA-N

文献信息

• Inhalable Formulation of a Solution Containing Tiotropium Bromide and Olodaterol
  申请人：Huang Cai Gu

  公开号：US20210322311A1

  公开（公告）日：2021-10-21

  The present invention relates to a liquid, propellant-free pharmaceutical preparation and a method for administering the pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises a solvent, Tiotropium or a pharmaceutically acceptable salt thereof, Olodaterol or a pharmaceutically acceptable salt thereof, a pH adjusting agent, and a pharmacologically acceptable additive.
• [EN] INHALABLE FORMULATION OF A SOLUTION CONTAINING TIOTROPIUM BROMIDE AND OLODATEROL<br/>[FR] FORMULATION INHALABLE D'UNE SOLUTION CONTENANT DU BROMURE DE TIOTROPIUM ET DE L'OLODATÉROL
  申请人：[en]ANOVENT PHARMACEUTICAL (U.S.), LLC

  公开号：WO2021211858A1

  公开（公告）日：2021-10-21

  The present invention relates to a liquid, propellant-free pharmaceutical preparation and a method for administering the pharmaceutical preparation by nebulizing the pharmaceutical preparation in an inhaler. The propellant-free pharmaceutical preparation comprises a solvent, Tiotropium or a pharmaceutically acceptable salt thereof, Olodaterol or a pharmaceutically acceptable salt thereof, a pH adjusting agent, and a pharmacologically acceptable additive.